港股異動 | 卓悦控股(0653.HK)一度暴漲110% 與香港華為國際訂立諒解備忘錄
格隆匯5月5日丨卓悦控股(0653.HK)高開高走,盤中一度暴漲110%至0.385港元,現漲幅收窄至72.13%報0.315港元,暫成交1565萬港元,最新總市值10.75億港元。卓悦控股昨日晚間公佈,於2021年5月4日,公司的全資附屬公司卓悦科技服務有限公司與香港華為國際有限公司就應用新零售科技服務創新以支持集團的業務轉型及可持續發展以及啟動集團與華為在聯合品牌營銷方面的合作訂立不具約束力的諒解備忘錄。鑑於可能進行的合作事項,董事認為,如果實現,將使集團能夠進一步優化集團的電子商務零售及相關發展,提高其盈利能力,為公司股東帶來更可觀的回報。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.